Search

everythinglearnresearchcommunity

for

Search:↓

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Oral JAK inhibitors help regrow hair in alopecia patients.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Tofacitinib may help treat severe hair loss, but more research is needed.

Ruxolitinib can help regrow hair in severe alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.

A patient with complete hair loss regrew all her hair using tofacitinib.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Baricitinib successfully treated severe hair loss.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Baricitinib may effectively treat nail changes in alopecia areata.

The nanoemulsion with garlic oil, apple cider vinegar, and minoxidil could effectively treat alopecia areata.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.